​

Parabilis Medicines Ownership | Who Owns Parabilis Medicines?

OverviewRevenueFinancialsChart

Parabilis Medicines Ownership Summary

Parabilis Medicines is owned by 342.35% institutional investors, 7.03% insiders. Farther finance advisors is the largest institutional shareholder, holding 0.00% of PBLS shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.76% of its assets in Parabilis Medicines shares.

PBLS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockParabilis Medicines342.35%7.03%-249.37%
SectorHealthcare Stocks 245.30%12.08%-157.38%
IndustryBiotech Stocks 381.70%11.71%-293.40%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Farther finance advisors284.000.00%$9.17K
Cx institutional200.000.00%$6.00K
Gamma investing6.00-$194.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cx institutional200.000.00%$6.00K
Farther finance advisors284.000.00%$9.17K
Gamma investing6.00-$194.00

Top Buyers

HolderShares% AssetsChange
Farther finance advisors284.000.00%284.00
Cx institutional200.000.00%200.00
Gamma investing6.00-6.00

Top Sellers

HolderShares% AssetsChange
Gamma investing6.00-6.00
Cx institutional200.000.00%200.00
Farther finance advisors284.000.00%284.00

New Positions

HolderShares% AssetsChangeValue
Farther finance advisors284.000.00%284.00$9.17K
Cx institutional200.000.00%200.00$6.00K
Gamma investing6.00-6.00$194.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202680-98,966,494-342-80---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Health Sciences2.17M1.76%1.68M
HBM Healthcare Investments AG Ord1.19M0.97%1.19M
Vanguard MStar Total Stk Mkt Idx Invest1.12M0.91%-
iShares Russell 2000 ETF1.03M0.83%17.42K
Vanguard Small Cap Index809.53K0.66%364.00
Fidelity Growth Company Fund478.76K0.39%-
JPMorgan Small Cap Growth A472.81K0.38%-7.39K
Fidelity Select Biotechnology436.41K0.35%290.26K
Janus Henderson Hrzn Biotec E2 USD369.53K0.30%369.53K
Janus Henderson Global Life Sciences D354.00K0.29%30.45K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 22, 2026RA CAPITAL MANAGEMENT, L.P. Buy$1.41M
Jul 21, 2026RA CAPITAL MANAGEMENT, L.P. Buy$1.13M
Jul 21, 2026RA CAPITAL MANAGEMENT, L.P. Buy$189.72K
Jul 21, 2026RA CAPITAL MANAGEMENT, L.P. Buy$606.62K
Jul 20, 2026RA CAPITAL MANAGEMENT, L.P. Buy$914.40K

Insider Transactions Trends

DateBuySell
2026 Q36-

PBLS Ownership FAQ

Who Owns Parabilis Medicines?

Parabilis Medicines shareholders are primarily institutional investors at 342.35%, followed by 7.03% insiders and -249.38% retail investors. The average institutional ownership in Parabilis Medicines's industry, Biotech Stocks , is 381.70%, which Parabilis Medicines falls below.

Does Blackrock own Parabilis Medicines?

BlackRock is not among the top 10 institutional shareholders of Parabilis Medicines.

Who is Parabilis Medicines’s biggest shareholder by percentage of total assets invested?

Cx institutional is Parabilis Medicines’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 200 Parabilis Medicines shares, valued at 6K$.

Who is the top mutual fund holder of Parabilis Medicines shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Parabilis Medicines shares, with 1.76% of its total shares outstanding invested in 2.17M Parabilis Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools